All Panel Deletionduplication Detection

The ALL Panel – Deletion/Duplication Detection is a specialized genetic test used to identify deletions and duplications in genes associated with Acute Lymphoblastic Leukemia (ALL). These genetic alterations can influence the development and behavior of leukemia and provide important information for disease classification. By detecting changes in the number of copies of specific genes, the test supports a comprehensive genetic evaluation and helps healthcare providers better understand the molecular profile of the disease for diagnosis and treatment planning.

Who should get this test done?

This test may be recommended for individuals who:

●     Have a confirmed or suspected diagnosis of Acute Lymphoblastic Leukemia (ALL).

●     Require detailed genetic profiling as part of leukemia evaluation.

●     Need additional molecular testing to classify the type of ALL more accurately.

●     Are undergoing assessment to support treatment planning and risk evaluation.

●     Are advised by a hematologist or oncologist to undergo genetic testing for leukemia.

Why consider this test?

Acute Lymphoblastic Leukemia is driven by a variety of genetic changes, and identifying these alterations is an important part of understanding the disease. The ALL Panel – Deletion/Duplication Detection helps detect gains or losses of genetic material that may not be identified through routine laboratory testing. This detailed genetic information supports accurate disease classification, contributes to personalized treatment strategies, and provides valuable insights that can assist healthcare providers throughout the course of patient management.

More information

This test uses advanced molecular genetic techniques to evaluate genes associated with Acute Lymphoblastic Leukemia for copy number variations (CNVs), including deletions and duplications. It is often performed alongside other genetic investigations such as mutation analysis, chromosomal studies, or fusion gene testing to provide a comprehensive molecular profile of the disease. The findings are interpreted together with clinical features, blood and bone marrow examination, immunophenotyping, and other laboratory results to support a complete diagnostic assessment.

Other names

●     Acute Lymphoblastic Leukemia Deletion/Duplication Panel

●     ALL Copy Number Variation (CNV) Panel

●     ALL Gene Deletion and Duplication Analysis

●     ALL Genetic Deletion/Duplication Test

●     Acute Lymphoblastic Leukemia CNV Analysis